Zoledronate and Raloxifene combination therapy enhances material and mechanical properties of diseased mouse bone
Current interventions to reduce skeletal fragility are insufficient at enhancing both the quantity and quality of bone when attempting to improve overall mechanical integrity. Bisphosphonates, such as Zoledronate (ZOL), are used to treat a variety of bone disorders by increasing bone mass to decreas...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | en_US |
| Published: |
Elsevier
2021
|
| Online Access: | Powell, K. M., Skaggs, C., Pulliam, A., Berman, A., Allen, M. R., & Wallace, J. M. (2019). Zoledronate and Raloxifene combination therapy enhances material and mechanical properties of diseased mouse bone. Bone, 127, 199–206. https://doi.org/10.1016/j.bone.2019.06.018 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|